InterCure Ltd. INCR
Set alert
3.97 USD -0.15 -3.64%
At close · Oct 30
3.97 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
3.97 Day range 4.20
3.65 52-week range 7.30
- YTD
- -12.75%
- 1 year
- -43.29%
- Open
- 4.17
- Prev close
- 4.12
- Mkt cap
- 59.56M
- Vol
- 14.67K
- Avg vol
- 22.01K
- EPS
- -0.95
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.97
- High
- 4.20
- Forward P/E
- -1.21
- Beta
- 0.03
- Short ratio
- 0.73
- Inst. own
- 11.61%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.52
- 200-d avg
- 2.14
- 1y target
- 0.00
2Y chart
Events in this range
- Aug 24, 2026Split: 1 for 5
Signals (77)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 2026 | 1 day ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 2 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 7, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| SMA: Bearish | Jun 10, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 29, 2026 | 5 months ago |
| RSI: Overbought | May 28, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| MACD: Sell Signal | May 11, 2026 | 5 months ago |
| RSI: Overbought | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 22, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 27, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 25, 2026 | 7 months ago |
| RSI: Oversold | Mar 25, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 20, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 27, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 26, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 16, 2026 | 9 months ago |
| RSI: Oversold | Dec 29, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 23, 2025 | 10 months ago |
| SMA: Bearish | Dec 19, 2025 | 10 months ago |
| SMA: Bullish | Dec 16, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 12, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 10, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| SMA: Bearish | Oct 21, 2025 | 1 year ago |
| SMA: Bullish | Oct 17, 2025 | 1 year ago |
| SMA: Bearish | Oct 16, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 16, 2025 | 1 year ago |
| SMA: Bearish | Oct 15, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 30, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 17, 2025 | 1 year ago |
| SMA: Bullish | Sep 16, 2025 | 1 year ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 11, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 28, 2025 | 1 year ago |
| RSI: Overbought | Aug 12, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 16, 2025 | 1 year ago |
| SMA: Bearish | Jul 15, 2025 | 1 year ago |
| SMA: Bullish | Jul 8, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jul 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 3, 2025 | 1 year ago |
| SMA: Bearish | Jun 25, 2025 | 1 year ago |
| MACD: Sell Signal | May 15, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 16, 2025 | 1 year ago |
| RSI: Oversold | Apr 1, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 18, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 14, 2025 | 1 year ago |
| SMA: Bearish | Feb 26, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 27, 2025 | 1 year ago |
Key statistics
- Market cap
- 81.92M
- Enterprise value
- 203.36M
- Trailing P/E
- 0.00
- Forward P/E
- -1.21
- PEG ratio
- 0.00
- Price / sales
- 0.30
- Price / book
- 0.19
- EPS (TTM)
- -0.38
- Beta
- 0.03
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -24.07%
- Revenue (TTM)
- 272.67M
- Revenue growth
- -38.60%
- Free cash flow
- 0
- Total cash
- 20.30M
- Total debt
- 150.81M
- Return on equity
- -13.61%
- Shares outstanding
- 45.77M
- Short % of float
- 0.15%
- 50-day average
- 1.52
- 200-day average
- 2.14
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
INCR Revenue — quarterly 102.44M
INCR Net income — quarterly 4.88M
INCR EPS — quarterly 0.525
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 31, 2023 | Jun 1, 2023 | 0.00 | 0.03 | — | — |
| May 15, 2023 | Mar 1, 2023 | 0.00 | 0.00 | — | — |
| Mar 31, 2023 | Dec 1, 2022 | 0.00 | 0.05 | — | — |
| Nov 15, 2022 | Sep 1, 2022 | 0.00 | 0.05 | — | — |
| Aug 15, 2022 | Jun 1, 2022 | 0.00 | 0.10 | — | — |
| May 16, 2022 | Mar 1, 2022 | 0.00 | 0.11 | — | — |
About InterCure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Israel
- Website
- intercure.co
News
- Comparing Tilray Brands (NASDAQ:TLRY) and InterCure (NASDAQ:INCR)
- InterCure Regains Nasdaq Compliance
- InterCure Regains Compliance with Nasdaq Minimum Bid Price Requirement
- InterCure (NASDAQ:INCR) & Silo Pharma (NASDAQ:SILO) Financial Review
- InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages
- InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
- InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition
- InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
- InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
- InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
Your note
Sign in to keep a note on INCR — it syncs with the Stock Master app.